Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Children with obesity face increased risk for gallstones

Children who are overweight or obese face an increased risk for gallstones, according to a Kaiser Permanente study published in the Journal of Pediatric Gastroenterology & Nutrition.

26 Aug 2012

Study addresses important early risk factors of cardiovascular health in adolescents

Early exposure to tobacco smoke is associated with various adverse health outcomes in children and adolescents, including low birth weight and impaired lung growth and function.

26 Aug 2012

Cocoa and blood pressure: an interview with Dr Karin Ried

The compounds in cocoa responsible for blood pressure reduction are called flavanols or polyphenols. Flavanols are also found in green tea, dark berries or red wine.

24 Aug 2012

Women with heart attack symptoms receive lower quality of care than men

A new study published recently in the American Journal of Medicine, conducted by researchers in the Cardiac and Vascular Institute at NYU Langone Medical Center, found there was significantly lower quality of care and worse outcomes in women compared to men - particularly young women under age 35 who had heart attack symptoms.

23 Aug 2012

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

23 Aug 2012

Power Over Pressure steering committee launches world's first hypertension online resource

The Power Over Pressure steering committee today announced the launch of the world's first online resource created to help healthcare professionals improve diagnosis and develop solutions for treatment-resistant hypertension, an urgent and growing public health issue that affects 120 million people worldwide.

23 Aug 2012

Statin's potency may cause muscle problems in patients with cardiovascular disease

A study from the University of California, San Diego School of Medicine, published August 22 online by PLoS ONE, reports that muscle problems reported by patients taking statins were related to the strength or potency of the given cholesterol-lowering drugs.

23 Aug 2012

Downward trend for heart failure in Canada

The incidence of heart failure in Ontario, Canada, substantially decreased between 1997 and 2008, a study suggests.

22 Aug 2012

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

Heart calcium scans are far superior to other assessment tools in predicting the development of cardiovascular disease in individuals currently classified at intermediate risk by their doctors, according to researchers at Wake Forest Baptist Medical Center.

22 Aug 2012

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Oxygen Biotherapeutics, Inc., announced today that recent research conducted by its partner, Aurum Biosciences, Glasgow, Scotland, has shown that Oxycyte, OBI's proprietary perfluorocarbon-based intravenous emulsion, improves imaging of the penumbra following acute ischemic stroke in a rat model.

22 Aug 2012

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

22 Aug 2012

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.

22 Aug 2012

HDL cholesterol benefits reduced with high C-reactive protein

The cardioprotective effects of high-density lipoprotein cholesterol are compromised in the presence of elevated high-sensitivity C-reactive protein, report researchers.

21 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

Berry wines may help people with diabetes decrease their blood sugar

In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.

21 Aug 2012

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

The MitoTarget Project was a project funded by the European Commission, under their FP7 programme. It was funding for a call published in 2007.

21 Aug 2012

Siemens, Arkansas complete $10M agreement for Soarian health IT solution

Siemens recently completed a 10-year, $10 million agreement, which included $4.8 million of financing, with Arkansas Heart Hospital for the acquisition and implementation of the Soarian® healthcare information technology (IT) solution.

From Siemens Healthineers 21 Aug 2012

Study finds decline in incidence of heart failure cases in Ontario

The number of new cases of heart failure in Ontario decreased 33% over a decade, suggesting preventive efforts may be working. However, mortality rates remain high for people with the disease, states a study published in CMAJ (Canadian Medical Association Journal).

21 Aug 2012

Heart-healthy chocolate lowers blood pressure

Results from a systematic review and meta-analysis suggest that regular consumption of flavanol-rich cocoa powder or chocolate reduces blood pressure by a small but significant amount.

20 Aug 2012

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Juventas Therapeutics, a privately-held clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, reports treating the first patient in its STOP-HF trial.

20 Aug 2012

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Children with obesity face increased risk for gallstones

Study addresses important early risk factors of cardiovascular health in adolescents

Cocoa and blood pressure: an interview with Dr Karin Ried

Women with heart attack symptoms receive lower quality of care than men

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

Power Over Pressure steering committee launches world's first hypertension online resource

Statin's potency may cause muscle problems in patients with cardiovascular disease

Downward trend for heart failure in Canada

Coronary artery calcium tool proves effective in detecting risk of cardiovascular disease

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

CIRT to determine whether methotrexate can reduce heart attacks, strokes and CVD deaths

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

HDL cholesterol benefits reduced with high C-reactive protein

CHD patients do not need to rule out high-intensity exercise

Berry wines may help people with diabetes decrease their blood sugar

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

Siemens, Arkansas complete $10M agreement for Soarian health IT solution

Study finds decline in incidence of heart failure cases in Ontario

Heart-healthy chocolate lowers blood pressure

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in